Search

Your search keyword '"Teo, Soo"' showing total 1,290 results

Search Constraints

Start Over You searched for: Author "Teo, Soo" Remove constraint Author: "Teo, Soo"
1,290 results on '"Teo, Soo"'

Search Results

202. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

203. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women

204. GermlineAPOBEC3Bdeletion in Asian women increases somatic hypermutation in breast cancer that is associated with Her2 subtype,PIK3CAmutations, immune activation, and increased survival

206. Health system strengthening: Integration of breast cancer care for improved outcomes

207. The Molecular Landscape of Asian Breast Cancers Reveals Clinically Relevant Population-Specific Differences

208. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants

209. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

210. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

211. Measurement challenge: protocol for international case–control comparison of mammographic measures that predict breast cancer risk

212. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

216. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women

217. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer

218. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

219. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

220. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

221. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

222. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

223. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

224. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

225. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

226. Measurement challenge: protocol for international case–control comparison of mammographic measures that predict breast cancer risk

227. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

228. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.

229. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

230. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

231. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

232. The BRCA2 c.68-7T > A variant is not pathogenic:A model for clinical calibration of spliceogenicity

233. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

234. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

235. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry

236. Identifying 31 novel breast cancer susceptibility loci using data from genome-wide association studies conducted in Asian and European women

237. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

238. Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast Cancer

239. An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma

240. The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium

241. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women

242. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

244. Patient-reported outcome measures among breast cancer survivors: A cross-sectional comparison between Malaysia and high-income countries.

245. Characterisation of protein-truncating and missense variants in PALB2in 15 768 women from Malaysia and Singapore

246. Oncologist-led BRCAcounselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

249. Feasibility of Patient Navigation to Improve Breast Cancer Care in Malaysia

Catalog

Books, media, physical & digital resources